Application of IL-17A Inhibitors in Psoriasis Complicated by Multiple Infections – Successful Treatment and Insights from a Case of Psoriasis with HIV and Neurosyphilis
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0392Keywords:
Plaque psoriasis, Neurosyphilis, HIV, IL-17A inhibitorDownloads
References
Sanguinetti J, Suar L, Eimer L, Busso C. Successful treatment with risankizumab in a patient with psoriasis and HIV. Medicina 2022; 82: 605–608.
Morar N, Willis-Owen SA, Maurer T, Bunker CB. HIV-associated psoriasis: pathogenesis, clinical features, and management. Lancet Infect Dis 2010; 10: 470–478. DOI: https://doi.org/10.1016/S1473-3099(10)70101-8
Lambert JLW, Segaert S, Ghislain PD, Hillary T, Nikkels A, Willaert F, et al. Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2). J Eur Acad Dermatol Venereol 2020; 34: 1914–1923. DOI: https://doi.org/10.1111/jdv.16683
Smith CH, Jabbar-Lopez ZK, Yiu ZZ, Bale T, Burden AD, Coates LC, et al. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017. Br J Dermatol 2017; 177: 628–636. DOI: https://doi.org/10.1111/bjd.15665
Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol 2019; 80: 1029–1072. DOI: https://doi.org/10.1016/j.jaad.2018.11.057
Xu J, Gill K, Flora A, Kozera E, Frew JW. The impact of psoriasis biologic therapy on HIV viral load and CD4+ cell counts in HIV-positive individuals: a real-world cohort study. J Eur Acad Dermatol Venereol 2023; 37: 1659–1663. DOI: https://doi.org/10.1111/jdv.19020
Rob F, Rozsypal H. Successful treatment of psoriasis with risankizumab in an HIV positive patient with sexually transmitted infection comorbidities. Dermatol Ther 2022; 35: e15277. DOI: https://doi.org/10.1111/dth.15277
Gao JY, Hu HX, Xiao Y, Xia DM, Jiang L. Li W.Clinical analysis of eight cases of psoriasis complicated with HIV infection treated with biologics. Zhongguo Mafeng Pifubing Zazhi 2025; 41: 559–563.
Maione V, Rovaris S, Romanó C, Bighetti S, Arisi M, Carrera CG, et al. Exploring the impact of guselkumab and risankizumab on psoriasis in HIV-positive patients: insights from four Italian centers. Australas J Dermatol 2025; 66: 215–219. DOI: https://doi.org/10.1111/ajd.14467
Jing XL, Meng ZY, Zhu Y. A case of severe plaque psoriasis complicated with HIV infection treated with secukinumab. Pifuxingbing Zhenliaoxue Zazhi 2025; 32: 285–288.
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
